▼ 1.77%
prev close
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Congressional Trades
8
All tracked trades
Members Trading
6
Unique members
Net Activity
+4
6 buys · 2 sells
Members Who Traded This Stock
8 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-08 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 141d ago | — | |
| 2025-11-19 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 170d ago | — | |
| 2025-10-30 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 194d ago | — | |
| 2025-06-09 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 294d ago | — | |
| 2025-04-21 | AZNAstraZeneca PLC - American Depositary Shares | Sell | $1,001 - $15,000 | 387d ago | — | |
| 2025-03-03 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 413d ago | — | |
| 2024-10-29 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 264d ago | — | |
| 2023-07-10 | AZNAstraZeneca PLC - American Depositary Shares | Sell | $100,001 - $250,000 | 1025d ago | — |
2025-12-08
Julia Letlow
AZN
Amount
$1,001 - $15,000
Filed
141d ago
2025-11-19
Gilbert Cisneros
AZN
Amount
$1,001 - $15,000
Filed
170d ago
2025-10-30
Lisa McClain
AZN
Amount
$1,001 - $15,000
Filed
194d ago
2025-06-09
Lisa McClain
AZN
Amount
$1,001 - $15,000
Filed
294d ago
2025-04-21
Bruce Westerman
AZN
Amount
$1,001 - $15,000
Filed
387d ago
2025-03-03
Bruce Westerman
AZN
Amount
$1,001 - $15,000
Filed
413d ago
2024-10-29
Valerie Hoyle
AZN
Amount
$1,001 - $15,000
Filed
264d ago
2023-07-10
Daniel Goldman
AZN
Amount
$100,001 - $250,000
Filed
1025d ago
Recent News
Powered by Polygon.io
AstraZeneca Highlights Sustained Survival Benefit In Advanced Breast Cancer Study
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
Trade Timeline
Congressional activity, newest first
Julia Letlow
2025-12-08 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-11-19 · Purchase
$1,001 - $15,000
Lisa McClain
2025-10-30 · Purchase
$1,001 - $15,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Bruce Westerman
2025-04-21 · Sale
$1,001 - $15,000
Bruce Westerman
2025-03-03 · Purchase
$1,001 - $15,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-10 · Sale
$100,001 - $250,000